The pharmaceutical company Pfizer on Friday asked the Brazilian health surveillance agency (Anvisa) to authorize the use of its vaccine against Covid-19 in children aged 5 to 11, the agency said.
The Annvisa
"received the request from Pfizer to include the age group of 5 to 11 years in the indications of its vaccine Comirnaty"
, specifies a
press
release.
Read alsoCovid-19: the dubious medical experiences in Brazil
The authorization request provides that the dosage of the vaccine
"will be adapted and lower than that used for 12 years and over"
and will be distributed in different vials.
For its part, Pfizer said in a note that, according to a
"preliminary analysis"
,
"a schedule of two doses of 10 micrograms of vaccine has been shown to be safe and capable of generating a high level of antibodies"
in this segment
of the vaccine.
'age.
The Brazilian health regulator now has 30 days to study the request for Pfizer, whose vaccine has already been authorized for 5-11 year olds in the United States since November 2.
In Brazil, the Pfizer vaccine has been authorized since June 11 for 12-15 year olds, and since February 23 for those over 16 years old.
Read alsoJair Bolsonaro on the dock after the devastation of the Covid in Manaus
With 610,000 dead for 213 million inhabitants, Brazil is the most bereaved country, after the United States, by the coronavirus epidemic.
More than 58% of the population there received a complete vaccination schedule.
